duchenne muscular dystrophy
February 10th, 2017
Murdoch University’s Professor Steve Wilton shared insights into his groundbreaking work on developing a revolutionary new treatment for genetic disease with a worldwide audience at TEDx Perth.
September 20th, 2016
The international Duchenne muscular dystrophy community have applauded the announcement by the US Food and Drug Administration (FDA) to approve a drug developed in Perth by Professors Steve Wilton and Sue Fletcher
October 2nd, 2015
Murdoch University has signed a four-year agreement with Sarepta Therapeutics, with the purpose of using Sarepta’s phosphorodiamidate morpholino oligomer (PMO) technology and chemistry in researching and developing treatment solutions for diseases outside of Duchenne Muscular Dystrophy (DMD).
December 3rd, 2014
The Governor of Western Australia, Her Excellency the Honourable Kerry Sanderson AO visited the Western Australian Neuroscience Research Institute to become its official Patron.
November 5th, 2014
Murdoch University researchers from the Centre for Comparative Genomics (CCG) have received almost $800,000 in funding from the National Health and Medical Research Council (NHMRC) to develop genetic drugs to treat rare diseases.
September 5th, 2013
Two Murdoch University researchers won one of the nation's most prestigious awards, the Australian Museum Eureka Prizes. Professor Steve Wilton and Professor Sue Fletcher were awarded the NSW Health Jamie Callchor Eureka Prize for Medical Research Translation.
April 10th, 2013
Prominent molecular geneticists Professors Steve Wilton and Sue Fletcher have joined Murdoch’s Centre for Comparative Genomics (CCG).
October 1st, 2012
Murdoch University graduate Conor Murphy has not let Duchenne Muscular Dystrophy (DMD) stand in the way of earning a double degree in Politics and History.
September 7th, 2011
A Murdoch University graduate has faced more difficulties than most in her journey to a first class honours degree in biomedical science.